We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.7B
AUM Growth
+$211M
Cap. Flow
-$755M
Cap. Flow %
-5.94%
Top 10 Hldgs %
33.79%
Holding
1,215
New
45
Increased
450
Reduced
295
Closed
31

Top Buys

Rank Stock Value
1
VICI icon
VICI Properties
VICI
+$108M
2
VER
VEREIT, Inc.
VER
+$105M
3
WELL icon
Welltower
WELL
+$102M
4
VTR icon
Ventas
VTR
+$88.9M
5
BXP icon
Boston Properties
BXP
+$86.8M

Top Sells

Rank Stock Value
1
EQR icon
Equity Residential
EQR
+$189M
2
GGP
GGP Inc.
GGP
+$166M
3
KRC icon
Kilroy Realty
KRC
+$93.2M
4
ESRT icon
Empire State Realty Trust
ESRT
+$92.1M
5
EPR icon
EPR Properties
EPR
+$59.2M

Sector Composition

Rank Sector Weight
1 Real Estate 73.5%
2 Industrials 3.95%
3 Technology 3.75%
4 Financials 2.75%
5 Consumer Discretionary 2.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTMX icon
1076
CytomX Therapeutics
CTMX
$705M
$5K ﹤0.01%
212
– –
IOVA icon
1077
Iovance Biotherapeutics
IOVA
$2.23B
$5K ﹤0.01%
401
– –
OMER icon
1078
Omeros
OMER
$709M
$5K ﹤0.01%
265
– –
NSLR
1079
PUT
Neostellar Capital Corp
NSLR
$262M
$5K ﹤0.01%
923
-2,242
-71% -$13.2K
VNDA icon
1080
Vanda Pharmaceuticals
VNDA
$312M
$5K ﹤0.01%
248
– –
ITCI
1081
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$5K ﹤0.01%
302
– –
EPZM
1082
DELISTED
Epizyme, Inc
EPZM
$5K ﹤0.01%
383
– –
FLXN
1083
DELISTED
Flexion Therapeutics, Inc.
FLXN
$5K ﹤0.01%
207
– –
EVHC
1084
DELISTED
Envision Healthcare Holdings Inc
EVHC
$5K ﹤0.01%
106
-3,519
-97% -$145K
ADAP
1085
DELISTED
Adaptimmune Therapeutics
ADAP
$4K ﹤0.01%
323
– –
AMPH icon
1086
Amphastar Pharmaceuticals
AMPH
$825M
$4K ﹤0.01%
254
– –
ANIP icon
1087
ANI Pharmaceuticals
ANIP
$1.77B
$4K ﹤0.01%
64
– –
CERS icon
1088
Cerus
CERS
$587M
$4K ﹤0.01%
630
– –
CHRS icon
1089
Coherus Oncology
CHRS
$217M
$4K ﹤0.01%
320
– –
COLL icon
1090
Collegium Pharmaceutical
COLL
$1.14B
$4K ﹤0.01%
180
– –
KPTI icon
1091
Karyopharm Therapeutics
KPTI
$168M
$4K ﹤0.01%
17
– –
MGNX icon
1092
MacroGenics
MGNX
$235M
$4K ﹤0.01%
203
– –
RETA
1093
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$4K ﹤0.01%
110
– –
CCXI
1094
DELISTED
ChemoCentryx, Inc.
CCXI
$4K ﹤0.01%
269
– –
ADMS
1095
DELISTED
Adamas Pharmaceuticals
ADMS
$4K ﹤0.01%
142
– –
AMAG
1096
DELISTED
AMAG Pharmaceuticals
AMAG
$4K ﹤0.01%
195
– –
DOVA
1097
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$4K ﹤0.01%
142
– –
ECYT
1098
DELISTED
Endocyte, Inc. Common Stock
ECYT
$4K ﹤0.01%
265
– –
ACRS icon
1099
Aclaris Therapeutics
ACRS
$730M
$3K ﹤0.01%
170
– –
AKBA icon
1100
Akebia Therapeutics
AKBA
$327M
$3K ﹤0.01%
261
– –
42 43
44
45 46

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2018 Portfolio in Review

As of Q2 2018, Daiwa Securities Group held 1,215 positions worth $12.7B, up 1.7% from $12.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group withdrew a net $755M in Q2 2018, closing 31 positions and reducing 295 holdings. Its most notable exit was Blue Buffalo Pet Products, Inc, an estimated $5.82M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, up from 73% a quarter earlier, followed by Industrials and Technology.

Against the trend, Daiwa Securities Group opened a new position in VICI Properties worth $115M.

  • Daiwa Securities Group's largest Q2 2018 buy was VICI Properties: 5,575,176 shares worth $115M.
  • Daiwa Securities Group added most to VEREIT, Inc. in Q2 2018, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2018 reduction was Equity Residential, cutting an estimated $189M.
  • Daiwa Securities Group fully exited Blue Buffalo Pet Products, Inc in Q2 2018, selling an estimated $5.82M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $12.7B portfolio in Q2 2018.
  • Daiwa Securities Group opened 45 new positions and closed 31 in Q2 2018.
  • Daiwa Securities Group's portfolio value rose 1.7% quarter-over-quarter to $12.7B.

Based on Daiwa Securities Group's 13F filing for Q2 2018, filed 30 Jul 2018.